Holen Sie sich die Stockscreener-App
9.18
5.56%
-0.54
Handel nachbörslich:
9.49
0.31
+3.38%
Schlusskurs vom Vortag:
$9.72
Offen:
$9.43
24-Stunden-Volumen:
1.27M
Relative Volume:
1.41
Marktkapitalisierung:
$701.81M
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-3.1765
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
-6.61%
1M Leistung:
+1.55%
6M Leistung:
-6.80%
1J Leistung:
-63.51%
1-Tages-Spanne:
$9.14
$9.70
1-Wochen-Bereich:
$9.00
$10.88
52-Wochen-Spanne:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Vergleichen Sie NRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.18 | 747.31M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $15.00 at Morgan Stanley - MarketBeat
NRIX: Morgan Stanley Maintains Rating, Lowers Price Target to $1 - GuruFocus
NRIX: HC Wainwright & Co. Maintains Rating but Lowers Price Targ - GuruFocus
Using data models to predict Nurix Therapeutics Inc. stock movement2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
What technical charts say about Nurix Therapeutics Inc. stockPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Earnings visualization tools for Nurix Therapeutics Inc.2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Is Nurix Therapeutics Inc. forming a reversal patternPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
Nurix Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 4.4%Should You Sell? - MarketBeat
Can Nurix Therapeutics Inc. stock hit record highs againWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Will Nurix Therapeutics Inc. stock recover faster than peersTreasury Yields & AI Powered Market Entry Strategies - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - simplywall.st
Nurix Therapeutics (NRIX): Losses Worsen 21.7% Annually, Reinforcing Profitability Concerns Despite Growth Narrative - Yahoo Finance
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Down Following Weak Earnings - MarketBeat
Nurix: Bexobrutideg Advancement Presses Forward With H2 2025 Milestones (NASDAQ:NRIX) - Seeking Alpha
Nurix Therapeutics (NASDAQ:NRIX) Announces Quarterly Earnings Results - MarketBeat
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Strong Sell - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Trading 8.7% HigherStill a Buy? - MarketBeat
Oppenheimer Maintains Nurix Therapeutics (NRIX) Outperform Recommendation - Nasdaq
What analysts say about Nurix Therapeutics Inc stockTake Profit Strategies & Low Cost Portfolio Ideas - earlytimes.in
Nurix Therapeutics (NRIX) Stock Falls After Q3 Earnings Miss - GuruFocus
Using portfolio simulators with Nurix Therapeutics Inc. includedOil Prices & Accurate Technical Buy Alerts - newser.com
Is Nurix Therapeutics Inc. showing signs of accumulationJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Nurix Therapeutics (NRIX) Analyst Rating Update: Piper Sandler L - GuruFocus
Detecting price anomalies in Nurix Therapeutics Inc. with AIJuly 2025 Update & Short-Term High Return Ideas - newser.com
Nurix Therapeutics (NRIX) Price Target Lowered by Oppenheimer | - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Nurix Therapeutics (NRIX) Reports Wider Q3 Earnings Miss - GuruFocus
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
Nurix Therapeutics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Nurix Therapeutics Reports Third Quarter 2025 Financial Results And Provides A Corporate Update - TradingView
Nurix Therapeutics Doubles Down On Pivotal Trials Despite Losses - Finimize
Nurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Nurix Therapeutics Inc Reports Q3 2025 Earnings: EPS of ($1.03) Misses Estimates, Revenue at $7.9 Million Falls Short - GuruFocus
NRIX Q3 Revenue Falls Short; Future Research Endeavors Outlined - GuruFocus
Nurix Therapeutics shares tumble 9% on wider-than-expected Q3 loss, revenue miss - Investing.com Nigeria
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - The Manila Times
Earnings Flash (NRIX) Nurix Therapeutics, Inc. Reports Q3 Revenue $7.9M, vs. FactSet Est of $16.0M - MarketScreener
How Nurix Therapeutics Inc. stock performs in weak economyQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Smart tools for monitoring Nurix Therapeutics Inc.’s price action2025 Sector Review & Technical Confirmation Trade Alerts - newser.com
What MACD and RSI say about Nurix Therapeutics Inc.2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com
Does Nurix Therapeutics Inc. qualify in momentum factor screeningPortfolio Return Report & Real-Time Buy Zone Alerts - newser.com
Nurix Therapeutics Inc Stock Analysis and ForecastGlobal Trade Effects & Low Cost Market Strategies - earlytimes.in
Using Bollinger Bands to evaluate Nurix Therapeutics Inc.2025 Support & Resistance & Low Risk Entry Point Guides - newser.com
Technical analysis overview for Nurix Therapeutics Inc. stockAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
Nurix Therapeutics Inc. stock trend forecastMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
What momentum shifts mean for Nurix Therapeutics Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
Nurix Therapeutics Inc.’s volatility index tracking explained2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nurix Therapeutics Inc-Aktie (NRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| van Houte Hans | Chief Financial Officer |
Aug 01 '25 |
Sale |
11.03 |
5,402 |
59,598 |
35,512 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):